Read Eli Lilly's Investigational Drug Shows Potential in Diabetes Management LifeMedicine Eli Lilly's Investigational Drug Shows Potential in Diabetes Management Eli Lilly's investigational drug, known as 'triple-G', has demonstrated significant effects on blood sugar and weight in a late-stage diabetes trial. Editorial Staff Updated 5 days ago